Eledon Pharmaceuticals In... (ELDN)
NASDAQ: ELDN
· Real-Time Price · USD
2.84
0.08 (2.90%)
At close: Oct 03, 2025, 3:59 PM
2.86
0.70%
After-hours: Oct 03, 2025, 07:31 PM EDT
Eledon Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.22M | -6.5M | -44.62M | 63.63M | -44.91M | -10.29M | -9.63M | -10.35M | -9.58M | -10.77M | -58.38M | -10.47M | -9.25M | -9.86M | -8.81M | -9.82M | -7.38M | -8.5M |
Depreciation & Amortization | n/a | n/a | 88K | 79K | 97K | 95K | 94K | 94K | 94K | 92K | 93K | 93K | 94K | 93K | 61K | 44K | 44K | 46K |
Stock-Based Compensation | 2.69M | 2.86M | 6.58M | 1.78M | 3.06M | 1.69M | 1.71M | 1.73M | 1.72M | 1.38M | 1.47M | 2.19M | 2.31M | 2.19M | 2.05M | 2.04M | 2.03M | 1.77M |
Other Working Capital | -1.07M | 650K | -477K | 255K | 1.37M | -186K | -1.69M | -1.24M | 226K | 1.02M | -3.39M | 709K | 1.67M | 830K | -4.08M | 1.32M | -1.55M | -206K |
Other Non-Cash Items | -8.13M | -10.68M | 20.05M | -84.07M | 30.81M | -500K | 265K | -1.73M | -1.72M | 2.58M | 48.65M | -542K | 2.14M | 3.77M | 2.01M | 760K | 3.73M | -354K |
Deferred Income Tax | n/a | n/a | 431K | n/a | n/a | n/a | -889K | 1.25M | 1.62M | -2.58M | n/a | 542K | -2.14M | n/a | -579K | -686K | -588K | -501K |
Change in Working Capital | -1.07M | -1.75M | -1.52M | 6.8M | 3.16M | 265K | -685K | -3.25M | -359K | -625K | -1.31M | 3.62M | 628K | -571K | -1.94M | 1.32M | -1.55M | 2.01M |
Operating Cash Flow | -17.71M | -16.06M | -18.99M | -11.77M | -7.77M | -8.74M | -9.13M | -12.25M | -8.22M | -9.92M | -9.48M | -4.57M | -6.22M | -8.16M | -9.21M | -7.09M | -7.45M | -5.17M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -27.4M | -31.85M | -72.78M | -34.12M | -36.31M | -12.92M | -17.92M | -30.03M | -30.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 42.36M | 35.74M | 25.4M | 21.32M | 16.4M | 22.7M | 28M | 5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.03K | -30.33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 14.96M | 3.89M | -47.38M | -12.8M | -19.91M | 9.78M | 10.08M | -25.03M | -30.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -451K | 1K | n/a | -450K |
Financial Cash Flow | n/a | 115K | 80.17M | 5.28M | 48.07M | 1K | n/a | n/a | 33.02M | n/a | n/a | n/a | n/a | n/a | -450K | 1K | n/a | -450K |
Net Cash Flow | -2.75M | -12.05M | 13.8M | -19.29M | 20.38M | 1.04M | 945K | -37.28M | -5.54M | -9.92M | -9.48M | -4.57M | -6.22M | -8.16M | -9.21M | -7.09M | -7.45M | -5.62M |
Free Cash Flow | -17.71M | -16.06M | -18.99M | -11.77M | -7.77M | -8.74M | -9.13M | -12.25M | -8.22M | -9.92M | -9.48M | -4.57M | -6.22M | -8.16M | -9.21M | -7.09M | -7.45M | -5.17M |